While an increasing number of options exist for effectively treating patients with HIV infection, many clinicians find it challenging to keep abreast of important developments in HIV therapeutics. To address this problem, this CME dinner program series will use case studies to highlight and discuss the relative merits and clinical significance of new findings in HIV medicine presented at the 7th IAS Conference on HIV Pathogenesis, Treatment and Prevention (7th IAS).
Because the focus of the dinner programs will be on case studies, participants will need to be familiar with data from the 7th IAS that may be applied and discussed. Therefore, prior to attending a dinner program, participants will view an Internet presentation that summarizes and discusses the key data presented at the 7th IAS. As a result of this blended learning approach, participants will not only gain an increased understanding of key data presented at the 7th IAS, they will also be prepared to use these data in the clinic to address HIV-positive patients' health needs and provide the optimal care available, which will help to improve virologic suppression and antiretroviral adherence, increase the delivery of individualized care, reduce resistance and treatment failure, and improve patient outcomes and quality of life.
This activity is intended for physicians, physician assistants, advanced practice nurses, and other health care professionals involved in the treatment and management of patients with HIV infection.
After completing this activity, participants should be able to:
Use in a clinical setting findings from key new studies on HIV/AIDS diagnosis, management and treatment presented at the 7th IAS;
State the current treatment paradigms for HIV/AIDS, including the studies and data presented at the 7th IAS, and use that understanding to improve patient care;
Discuss with patients and colleagues the studies and data on newer therapies for HIV/AIDS presented at the 7th IAS and use that discussion to decide on appropriate planning of therapy for patients with HIV/AIDS.
| Wednesday, July 10, 2013 Los Angeles, CA |
Thursday, July 18, 2013 Miami, FL |
| Thursday, July 11, 2013 San Francisco, CA |
Tuesday, July 23, 2013 San Diego, CA |
| Tuesday, July 16, 2013 Houston, TX |
Wednesday, July 24, 2013 Phoenix, AZ |
| Wednesday, July 17, 2013 Chicago, IL |
Thursday, July 25, 2013 Durham, NC |
| Thursday, July 18, 2013 New York, NY |
Wednesday, July 31, 2013 Baltimore, MD |
Calvin J. Cohen, MD, MS
Research Director
CRI New England
Clinical Instructor
Harvard Medical School
Boston, Massachusetts
|
Richard A. Elion, MD |
David Wohl, MD Associate Professor of Medicine Division of Infectious Diseases The University of North Carolina School of Medicine Co-Director of HIV Services for the North Carolina Department of Corrections Chapel Hill, North Carolina |
|
Ian Frank, MD Professor of Medicine Director, Antiretroviral Clinical Research University of Pennsylvania Philadelphia, Pennsylvania |
Andrew Zolopa, MD Professor of Medicine Division of Infectious Diseases Stanford University School of Medicine Palo Alto, California |
|
Trevor Hawkins, MD Associate Clinical Professor Department of Family Practice University of New Mexico Medical Director, Southwest C.A.R.E. Santa Fe, New Mexico |
|
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and ViralEd, Inc.. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The Postgraduate Institute for Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)TM.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality CME activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.
Supported by an educational grant from Gilead Sciences Medical Affairs.
This coverage is not sanctioned by the conference organizers and is not an official part of the conference proceedings.
